Bolden Therapeutics, Inc.

Biotechnology company · Providence, Rhode Island, United States

Bolden Therapeutics, Inc. is a biotechnology company headquartered in Providence, Rhode Island, United States. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $2.3 million in total, most recently in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Bolden Therapeutics at a glance

Typebiotechnology company

HeadquartersProvidence, Rhode Island, United States

Employees (self-reported, 2024)3

What does Bolden Therapeutics do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $2.3 million in total (2021 to 2024). NIH funding came from the National Institute on Aging.

Frequently asked questions about Bolden Therapeutics

Where is Bolden Therapeutics headquartered?

Bolden Therapeutics, Inc. is headquartered in Providence, Rhode Island, United States.

What does Bolden Therapeutics do?

Bolden Therapeutics, Inc. is a biotechnology company.

Similar companies

Prothera Biologics, Inc.Providence, Rhode Island, United States
Plans4Care INCProvidence, Rhode Island, United States
Vitae Industries, IncProvidence, Rhode Island, United States
Epivax, Inc.Providence, Rhode Island, United States
Sention, Inc.Providence, Rhode Island, United States
Lucidicor Inc.Providence, Rhode Island, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences